Alzheimer's Drug

Lacanomab is an Alzheimer's drug and development by ASI and Biogen. The magnitude of that benefit is something that is hotly debated, right? There are people who believe that the slowing of the progression of Alzheimer's that we're seeing with Lacanomab is meaningful for patients. You know, these types of amyloid targeting drugs do cause brain bleeds and hemorrhages in the brain called the aria.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.